Will Trade Under News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InterCure Ltd. (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “ Company”) is pleased to announce that further to its confidential filing with the U.S. Securities and Exchange Commission (the “ SEC“) of its 20F registration statement on April 20, 2021, it will publicly file its 20F registration statement the week of July 11. The Company has also applied to list its common shares (the “ Common Shares“) on the NASDAQ Capital Market (“ NASDAQ“) under the trading symbol “INCR”, pending the public filing of the 20F registration statement and the satisfaction of certain other conditi...

solid demand TORONTO and HERZLIYA, Israel, May 20, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(“InterCure” or the “Company”) today announced that it signed a definitive agreement to acquire a licensed active medical cannabis trading house and two pharmacies. The trading house is approved by the Israeli Medical Cannabis Agency (IMCA) and is one of the leading operating trading houses in the country, authorized to distributing GMP medical cannabis products to pharmacies. As part of GMP regulations, medical cannabis products can dispense through IMCA ...

InterCure Announces Preliminary First Quarter Record Financial Results Revenues , InterCure by the end of Q2 HERZLIYA, Israel, May 09, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(the “Company”) today announced preliminary financial results for the first quarter of 2021. Preliminary First Quarter 2021 Highlights Record revenue expected to be an estimated NIS 33 million, 8 times greater than Q1 2020 and an increase of more than 22% compared to Q4 2020; Continued increase in operating profit, EBITDA and net profit; Continued market share growth due to ...

Canaccord Genuity initiates analyst coverage on InterCure USA - English Share this article Share this article TORONTO and HERZLIYA, Israel, May 10, 2021 /PRNewswire/ -- InterCure Ltd. (TSX: INCR:U) (TASE: INCR) (dba Canndoc)(the "Company") announced today that CanaccordGenuity Group Inc. ("CG") has initiated analyst coverage on InterCure. CG's initial research report and all future reports (if any) may be obtained directly from CG. Please note that any opinions, estimates or forecasts regarding the performance of InterCure and its management made by CG are theirs alone and do not represent th...

Nachrichtenquelle: globenewswire  |  24.04.2021, 00:55  |  102   |  0  InterCure is the Most Well-Capitalized Cannabis Company in Israel and is Positioned to Consolidate the Israeli Market and Further Expand Across Europe Combined Company led by Chairman and Former Prime Minister of Israel Ehud Barak and CEO Alex Rabinovitch InterCure has Doubled Revenues Sequentially in Four of the Last Five Quarters; Growth Plans Include Tripling Retail Footprint by 2022 Common Shares of InterC...